<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Antiangiogenic Tumor Treatment" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/antiangiogenic-tumor-treatment/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/antiangiogenic-tumor-treatment/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2010-04-30T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Antiangiogenic Tumor Treatment" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-07T07:15:32+00:00","datePublished":"2010-04-30T17:00:00+00:00","description":"Rationale and Objectives","headline":"Antiangiogenic Tumor Treatment","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/antiangiogenic-tumor-treatment/"},"url":"https://clinicaltree.github.io/posts/antiangiogenic-tumor-treatment/"}</script><title>Antiangiogenic Tumor Treatment | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Antiangiogenic Tumor Treatment</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Antiangiogenic Tumor Treatment</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1272646800" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 30, 2010 </em> </span> <span> Updated <em class="" data-ts="1680851732" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 7, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Jianhua Zhou MD PhD</a> </em>, <em> <a href="">Wei Zheng MD</a> </em>, <em> <a href="">Longhui Cao MD</a> </em>, <em> <a href="">Min Liu MD</a> </em>, <em> <a href="">Feng Han MD</a> </em>, <em> <a href="">Anhua Li MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1662 words"> <em>9 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>This study was designed to test the feasibility of contrast pulse sequencing imaging for contrast-enhanced grayscale ultrasound in assessing the effects of antiangiogenic therapy.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Mice with subcutaneously implanted H22 mouse hepatoma were treated with thalidomide or placebo by oral gavage over 7 days, starting at 24 hours after implantation. Contrast pulse sequencing ultrasound imaging was performed on day 8 to evaluate maximal cross-sectional area and nonenhanced area. Immediately after imaging, mice were euthanized, and tumor tissue was removed for fixation in a 10% formalin solution. The section equivalent to the ultrasound imaging plane was stained with hematoxylin and eosin to allow for the assessment of the largest cross-sectional area and necrotic area.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>There was no significant difference in tumor volume between the two groups. The difference of largest cross-sectional area determined by the two methods was not significant between control and treated tumors ( <em>P</em> &gt; .05). The nonenhanced area and its percentage evaluated by ultrasound were significantly larger in treated tumors than in control tumors ( <em>P</em> &lt; .05). The necrotic area and its percentage estimated by pathology slice were also significantly larger in treated tumors than in control tumors ( <em>P</em> &lt; .05). The largest cross-sectional area determined by the two methods was well correlated ( <em>r</em> = 0.815, <em>P</em> &lt; .001). There was good correlation between the nonenhanced area on ultrasound and the necrotic area on pathology slides ( <em>r</em> = 0.909, <em>P</em> &lt; .001). The percentage of nonenhanced area was well correlated with the percentage of necrotic area ( <em>r</em> = 0.910, <em>P</em> &lt; .001).</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Contrast-enhanced grayscale ultrasound with contrast pulse sequencing imaging provides a tool for early monitoring of antiangiogenic treatment of tumors, before apparent change in tumor size.</p><p>One of the most important recent developments in the field of oncology is the introduction of vascular targeting agents into clinical medicine. Contrary to cytotoxic agents, angiogenic inhibitors do not act directly on tumor cells but on endothelial cells, which very frequently induce lesion necrosis with no change in the volume of the initial tumor . The morphologic criteria normally used (World Health Organization or Response Evaluation Criteria in Solid Tumors) may not be the most appropriate endpoints for evaluating antiangiogenic agents . Additionally, these treatments have important side effects and high prices. As a consequence, animal and clinical trials will urgently require the development of reliable and noninvasive methods for the early evaluation of therapeutic efficacy.</p><p>Currently, histologic determination of the mean intratumoral microvessel density is the most commonly used method for assessing angiogenesis , but it is also the most invasive procedure. An additional limitation of this approach is that it does not provide information on effective perfusion through a vessel. Moreover, it reflects only a single point in time and cannot be used as a way of monitoring in vivo changes induced by antiangiogenic therapy. Importantly, although microvessel density can be used to predict disease progression, it has no value in monitoring or predicting response to antiangiogenic therapy .</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="animal-model"><span class="mr-2">Animal Model</span><a href="#animal-model" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="ultrasound-imaging-protocol"><span class="mr-2">Ultrasound Imaging Protocol</span><a href="#ultrasound-imaging-protocol" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="histologic-analysis"><span class="mr-2">Histologic Analysis</span><a href="#histologic-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="statistical-analysis"><span class="mr-2">Statistical Analysis</span><a href="#statistical-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="b-mode-imaging"><span class="mr-2">B-mode Imaging</span><a href="#b-mode-imaging" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="contrast-enhanced-grayscale-ultrasound"><span class="mr-2">Contrast-Enhanced Grayscale Ultrasound</span><a href="#contrast-enhanced-grayscale-ultrasound" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AntiangiogenicTumorTreatment/0_1s20S1076633210000589.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AntiangiogenicTumorTreatment/0_1s20S1076633210000589.jpg" alt="Figure 1, Box plot showing that nonenhanced area was significantly greater in tumors treated with thalidomide than in control tumors ( P = .003)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="histology"><span class="mr-2">Histology</span><a href="#histology" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AntiangiogenicTumorTreatment/1_1s20S1076633210000589.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AntiangiogenicTumorTreatment/1_1s20S1076633210000589.jpg" alt="Figure 2, Box plot showing that necrotic area was significantly greater in tumors treated with thalidomide than in control tumors ( P &lt; .001)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="comparison-of-contrast-enhanced-grayscale-ultrasound-and-histology"><span class="mr-2">Comparison of Contrast-Enhanced Grayscale Ultrasound and Histology</span><a href="#comparison-of-contrast-enhanced-grayscale-ultrasound-and-histology" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AntiangiogenicTumorTreatment/2_1s20S1076633210000589.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AntiangiogenicTumorTreatment/2_1s20S1076633210000589.jpg" alt="Figure 3, Comparison of contrast-enhanced ultrasound image at the time of maximal enhancement and histologic image (stained with hematoxylin and eosin) of a control (a,c) and a treated (b,d) tumor. (a,c) Contrast-enhanced ultrasound showing homogeneous enhancement in a control tumor (red arrow) and corresponding histologic image illustrated that no necrosis was developed. (b,d) Irregular nonenhanced region visible in a treated tumor (yellow arrow) and corresponding histologic image illustrating that significant necrosis (area within white boundary) was developed." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AntiangiogenicTumorTreatment/3_1s20S1076633210000589.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AntiangiogenicTumorTreatment/3_1s20S1076633210000589.jpg" alt="Figure 4, The largest cross-sectional area determined by ultrasound and histology was well correlated ( r = 0.815, P &lt; .001)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AntiangiogenicTumorTreatment/4_1s20S1076633210000589.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AntiangiogenicTumorTreatment/4_1s20S1076633210000589.jpg" alt="Figure 5, Scatterplots showing good correlation between nonenhanced area on ultrasound and necrotic area on histology ( r = 0.909, P &lt; .001)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AntiangiogenicTumorTreatment/5_1s20S1076633210000589.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/AntiangiogenicTumorTreatment/5_1s20S1076633210000589.jpg" alt="Figure 6, Significant correlation between the percentage of nonenhanced area and the percentage of necrotic area ( r = 0.910, P &lt; .001)." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Hlatky L., Hahnfeldt P., Folkman J.: Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J Natl Cancer Inst 2002; 94: pp. 883-893.</p><li><p>2. Padhani A.R., Neeman M.: Challenges for imaging angiogenesis. Br J Radiol 2001; 74: pp. 886-890.</p><li><p>3. Lassau M., Chebil M., Chami L., et. al.: A new functional imaging technique for the early functional evaluation of antiangiogenic treatment: dynamic contrast-enhanced ultrasonography (DCE-US). Targ Oncol 2008; 3: pp. 111-117.</p><li><p>4. Kerbel R., Folkman J.: Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2002; 2: pp. 727-739.</p><li><p>5. Tatum J.L., Hoffman J.M.: Role of imaging in clinical trials of antiangiogenesis therapy in oncology. Acad Radiol 2000; 7: pp. 798-799.</p><li><p>6. Miller J.C., Pien H.H., Sahani D., et. al.: Imaging angiogenesis: applications and potential for drug development. J Nat Cancer lnst 2005; 97: pp. 172-187.</p><li><p>7. Galbraith S.M.: Antivascular cancer treatments: imaging biomarkers in pharmaceutical drug development. Br J Radiol 2003; 76: pp. s83-s86.</p><li><p>8. Provenzale J.M.: Imaging of angiogenesis: clinical techniques and novel imaging methods. AJR Am J Roentgenol 2007; 188: pp. 11-23.</p><li><p>9. Gee M.S., Saunders H.M., Lee J.C., et. al.: Doppler ultrasound imaging detects changes in tumor perfusion during antivascular therapy associated with vascular anatomic alterations. Cancer Res 2001; 61: pp. 2974-2982.</p><li><p>10. Donnelly E.F., Geng L., Wojcicki W.E., et. al.: Quantified power Doppler US of tumor blood flow correlates with microscopic quantification of tumor blood vessels. Radiology 2001; 219: pp. 166-170.</p><li><p>11. Delorme S., Haberkorn U., Kinscherf R., et. al.: Changes of tumor vascularity during gene therapy monitored with color Doppler US. Ultrasound Med Biol 2001; 27: pp. 1595-1603.</p><li><p>12. Iordanescu I., Becker C., Zetter B., et. al.: Tumor vascularity evaluation in a murine model with contrast-enhanced color Doppler US-effect of angiogenesis inhibitors. Radiology 2002; 222: pp. 460-467.</p><li><p>13. Delorme S., Peschke P., Zuna I., et. al.: Imaging the smallest tumor vessels using color Doppler ultrasound in an experiment [article in German]. Radiologe 2001; 41: pp. 168-172.</p><li><p>14. Phillips P., Gardner E.: Contrast-agent detection and quantification. Eur Radiol 2004; 14: pp. 4-10.</p><li><p>15. Bleuzen A., Tranquart F.: Incidental liver lesions: diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue. Eur Radiol 2004; 14: pp. 53-62.</p><li><p>16. Wink M.H., de la Rosette J.J., Laguna P., et. al.: Ultrasonography of renal masses using contrast pulse sequence imaging: a pilot study. J Endourol 2007; 21: pp. 466-472.</p><li><p>17. Rissanen T.T., Korpisalo P., Karvinen H., et. al.: High-resolution ultrasound perfusion imaging of therapeutic angiogenesis. JACC: Cardiovasc Imaging 2008; 1: pp. 83-91.</p><li><p>18. Zhu B.D., Yuan S.J., Zhao Q.C., et. al.: Antitumor effect of Gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, combined with cytotoxic agent on murine hepatocellular carcinoma. World J Gastroenterol 2005; 11: pp. 1382-1386.</p><li><p>19. Kumarv V., Abbas A.K., Fausto , Aater J.C.: Robbins and Cotran pathologic basis of disease.8th ed.2007.SaundersPhiladelphia</p><li><p>20. Folkman J.: Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: pp. 1182-1186.</p><li><p>21. D’Amato R.J., Loughnan M.S., Flynn E., et. al.: Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A 1994; 91: pp. 4082-4085.</p><li><p>22. Kenyon B.M., Browne F., D’Amato R.J.: Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res 1997; 64: pp. 971-978.</p><li><p>23. Teo S.K.: Properties of thalidomide and its analogues: implications for anticancer therapy. AAPS J 2005; 7: pp. E14-E19.</p><li><p>24. Rissanen T.T., Korpisalo P., Markkanen J.E., et. al.: Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis. Circulation 2005; 112: pp. 3937-3946.</p><li><p>25. Cosgrove D.: Angiogenesis imaging ultrasound. Br J Radiol 2003; 76: pp. S43-S49.</p><li><p>26. Pollard R.E., Broumas A.R., Wisner E.R., et. al.: Quantitative contrast enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats. Ultrasound Med Biol 2007; 33: pp. 235-245.</p><li><p>27. Mendel D.B., Laird A.D., Xin X., et. al.: In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. Clin Cancer Res 2003; 9: pp. 327-337.</p><li><p>28. Broumas A.R., Pollard R.E., Bloch S.H., et. al.: Contrast-enhanced computed tomography and ultrasound for the evaluation of tumor blood flow. Invest Radiol 2005; 40: pp. 134-147.</p><li><p>29. De Giorgi U., Aliberti C., Benea G., et. al.: Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors. Clin Cancer Res 2005; 11: pp. 6171-6176.</p><li><p>30. Lassau N., Lamuraglia M., Chami L., et. al.: Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. AJR Am J Roentgenol 2006; 187: pp. 1267-1273.</p><li><p>31. Lamuraglia M., Le Cesne A., Chami L., et. al.: Dynamic contrast-enhanced Doppler ultrasound (DCE-US) is a useful radiological assessment to early predict the outcome of patients with gastrointestinal stromal tumors (GIST) treated with imatinib (IM) [abstract]. J Clin Oncol 2006; 24: pp. 9539.</p><li><p>32. Du G.J., Lin H.H., Xu Q.T., et. al.: Thalidomide inhibits growth of tumors through COX-2 degradation independent of antiangiogenesis. Vascul Pharmacol 2005; 43: pp. 112-119.</p><li><p>33. Kotoh T., Dhar D.K., Masunaga R., et. al.: Antiangiogenic therapy of human esophageal cancers with thalidomide in nude mice. Surgery 1999; 125: pp. 536-544.</p><li><p>34. Benjamin R.S., Choi H., Macapinlac H.A., et. al.: We should desist using RECIST, at least in GIST. J Clin Oncol 2007; 25: pp. 1760-1764.</p><li><p>35. Choi H., Charnsangavej C., Faria S.C., et. al.: Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria. J Clin Oncol 2007; 25: pp. 1753-1759.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-17/'>Volume 17</a>, <a href='/categories/issue-5/'>Issue 5</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Antiangiogenic%20Tumor%20Treatment%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fantiangiogenic-tumor-treatment%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Antiangiogenic%20Tumor%20Treatment%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fantiangiogenic-tumor-treatment%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fantiangiogenic-tumor-treatment%2F&text=Antiangiogenic%20Tumor%20Treatment%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/ct-guided-percutaneous-cryoneurolysis-for-post-thoracotomy-pain-syndrome/"><div class="card-body"> <em class="small" data-ts="1272646800" data-df="ll" > Apr 30, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>CT Guided Percutaneous Cryoneurolysis for Post Thoracotomy Pain Syndrome</h3><div class="text-muted small"><p> Rationale and Objectives The aim of this study was to determine the effect of cryoablation on pain levels in patients with histories of post-thoracotomy pain syndrome. Materials and Methods Eigh...</p></div></div></a></div><div class="card"> <a href="/posts/decision-analytic-model-for-evaluation-of-suspected-coronary-disease-with-stress-testing-and-coronar/"><div class="card-body"> <em class="small" data-ts="1272646800" data-df="ll" > Apr 30, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Decision Analytic Model for Evaluation of Suspected Coronary Disease with Stress Testing and Coronary CT Angiography</h3><div class="text-muted small"><p> Rationale and Objectives The aim of this study was to apply a decision analytic model for the evaluation of coronary artery disease (CAD) to define the optimal utilization of coronary computed tom...</p></div></div></a></div><div class="card"> <a href="/posts/direct-diagnosis-in-radiology-cardiac-imaging/"><div class="card-body"> <em class="small" data-ts="1272646800" data-df="ll" > Apr 30, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Direct Diagnosis in Radiology Cardiac Imaging</h3><div class="text-muted small"><p> Thieme’s entry on cardiac imaging in the Dx-Direct series is very impressive. Many factors (positive, of course) identified while reviewing this book prompted me to remark to myself that there woul...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/wireless-surveillance-for-transjugular-intrahepatic-portosystemic-shunts-tips/" class="btn btn-outline-primary" prompt="Older"><p>Wireless Surveillance for Transjugular Intrahepatic Portosystemic Shunts (TIPS)</p></a> <a href="/posts/ct-guided-percutaneous-cryoneurolysis-for-post-thoracotomy-pain-syndrome/" class="btn btn-outline-primary" prompt="Newer"><p>CT Guided Percutaneous Cryoneurolysis for Post Thoracotomy Pain Syndrome</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
